Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic advances in allergy and rhinology is Scopus-indexed (Q1, CiteScore 3.8), WoS ESCI. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2753-4030Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Otorhinolaryngology | 31 / 123 | 75th | Q1 |
| Immunology and Allergy | 144 / 234 | 38th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 3.8.
Therapeutic advances in allergy and rhinology is Q1 in Otorhinolaryngology (rank 31 of 123) and Q3 in Immunology and Allergy (rank 144 of 234), by CiteScore 2025.
Therapeutic advances in allergy and rhinology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.415, quartile Q3, with an H-index of 17.
Therapeutic advances in allergy and rhinology is published by SAGE Publications Ltd. Its ISSN is 2753-4030.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Therapeutic advances in allergy and rhinology has an h-index of 4 and a 2-year mean of 1.38 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q1. On 2-year citations it ranks #53 of 122 Scopus journals in Otorhinolaryngology.
Therapeutic advances in allergy and rhinology published 1 papers in 2025; its busiest recent year was 2023 with 10. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 16 research articles (2023–2026), authors are most often from United States (25%), Saudi Arabia (25%) and Thailand (12.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.